• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

1404-93-9 (Vancomycin (hydrochloride))

1

Identification

Vancomycin (hydrochloride) Vancomycin (hydrochloride)
Name Vancomycin (hydrochloride)
Formula
MW 0.0
CAS No. 1404-93-9
EINECS 215-772-6
Smiles
Synonyms
InChI
2

Introduction

Vancomycin hydrochloride is a hydrochloride of vancomycin that is a narrow-spectrum glycopeptide antibacterial agent. IC50 Value: Target: Antibacterial Vancomycin hydrochloride is a glycopeptide antibiotic that interferes with cell wall synthesis.

Background Information

The salt of a glycopeptide antibiotic isolated from amycolatopsis orientalis; exhibits potent activity against gram positive bacteria; highly effective against MRSA in vitro and in vivo; interferes with cell wall synthesis by binding to D-alanine-D-alanin ......by BOC Sciences
Vancomycin hydrochloride is an antibiotic for the treatment of bacterial infections. ......by MedChemexpress Co., Ltd.
Vancomycin hydrochloride (Vancocin) is used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin acts by inhibiting proper cell wall synthesis in Gram-positive bacteria. ......by Target Molecule Corp.
3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance:White to off-white Solid EBNumber:EB000018127

Storage condition

Solubility

DMSO by MedChemexpress Co., Ltd.
5

Mechanism and Indication

6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
Vancomycin (hydrochloride) - Launched
Vancomycin (hydrochloride) Massachusetts General Hospital MRSA infection 2013/9/30 2014/4/1 Phase 4 Clinical
Vancomycin (hydrochloride) Henry Ford Health System Nephrotoxicity 2011/10/31 Phase 4 Clinical
Vancomycin (hydrochloride) Cubist Pharmaceuticals Inc Bacterial infection 2012/12/31 2015/7/1 Phase 4 Clinical
Vancomycin (hydrochloride) Population Health Research Institute Infectious disease 2011/5/31 2013/6/30 Phase 4 Clinical
Vancomycin (hydrochloride) Sanofi Febrile neutropenia 2005/1/31 Phase 4 Clinical
7

Safety Data of Vancomycin (hydrochloride)

´╗┐Hazard Symbols : Xi
´╗┐Risk Statements : R43
Safety Statements : S24/25
RTECS : YW4380000
WGKGermany : 2
8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
BOC Sciences
CHEMSCENE, LLC 250mg/USD60();1g/USD72() USA
Cayman Chemical Company 250mg/USD39() USA
Clearsynth Labs Limited 25mg/USD100() India
EMD Millipore 250mg/USD72() USA
Fuzhou Borni Pharmaceutical Sci. & Tech. Co., Ltd. China
Glentham Life Sciences
Haikou Lancent Industrial Co., Ltd. China
J&K Scientific Ltd. 1g/RMB574();5g/RMB2284() China
MedChemexpress Co., Ltd. 250mg/USD60();1g/USD72() USA
MedKoo Biosciences, Inc. 10mg/USD60() USA
Nanjing Asian Chemical Co., Ltd. China
Pure Chemistry Scientific Inc. 0//USD124(In stock) USA
Santa Cruz Biotechnology, Inc. 250mg/USD55() USA
Selleck Chemicals LLC 50mg/USD84(In stock) USA
Shanghai Hanjing Chemicals Co., Ltd. China
Shanghai Haoyuan Chemexpress Co., Ltd. 250mg/USD60();1g/USD72() China
Shanghai Shamrock Imp. & Exp. Trading Co., Ltd. China
Sigma-Aldrich, Inc. 100mg/USD39();1g/USD149() USA
Spectrum Chemical Mfg. Corp. 1g/USD180() USA
Target Molecule Corp. 2mg/USD20();10mg/USD41();50mg/USD98();200mg/USD122() USA
Tocris Bioscience Inc. 1g/USD159() USA
10

Related Products

Other Forms of 1404-93-9

Name CAS No Formula MW
Vancomycin 1404-90-6 C66H76Cl3N9O24 1485.72

Recommended Compounds in Bacterial Autophagy

Name CAS No Formula MW
Fidaxomicin 873857-62-6 C52H74Cl2O18 1058.04
AVX 13616 900814-48-4 C50H73Cl2N7O7 955.06
Bedaquiline (fumarate) 845533-86-0 C36H35BrN2O6 671.58
Mafenide (Acetate) 13009-99-9 C9H14N2O4S 246.28
Cefozopran 113359-04-9 C19H17N9O5S2 515.53
Azithromycin 83905-01-5 C38H72N2O12 748.9845
Pazufloxacin 127045-41-4 C16H15FN2O4 318.3
Pazufloxacin (mesylate) 163680-77-1 C17H19FN2O7S 414.4054
Capreomycin (sulfate) 1405-37-4 C24H44N14O12S 752.76
Bleomycin (sulfate) 9041-93-4 C110H168N34O46S7 2927.17
G-418 (disulfate) 108321-42-2 C20H44N4O18S2 692.71
Demeclocycline (hydrochloride) 64-73-3 C21H22Cl2N2O8 501.31
Apramycin 37321-09-8 C21H41N5O11 539.58
Ceftriaxone 73384-59-5 C18H18N8O7S3 554.58
Ceftibuten 97519-39-6 C15H14N4O6S2 410.42
Dapsone 80-08-0 C12H12N2O2S 248.3
Vancomycin 1404-90-6 C66H76Cl3N9O24 1485.72
Lomefloxacin 98079-51-7 C17H19F2N3O3 351.35
Dirithromycin 62013-04-1 C42H78N2O14 835.07
Cefepime (Dihydrochloride Monohydrate) 123171-59-5 C19H28Cl2N6O6S2 571.5

Recommended Compounds in Same Indication

Name CAS No Formula MW
Besifloxacin (Hydrochloride) 405165-61-9 C19H22Cl2FN3O3 430.3
Moxifloxacin (Hydrochloride) 186826-86-8 C21H25ClFN3O4 437.89
Retapamulin 224452-66-8 C30H47NO4S 517.76
Omadacycline 389139-89-3 C29H40N4O7 556.65
Nystatin 1400-61-9 C47H75NO17 926.09
Linezolid 165800-03-3 C16H20FN3O4 337.35
Omadacycline (tosylate) 1075240-43-5 C36H48N4O10S 728.85
Omadacycline (mesylate) 1196800-40-4 C30H44N4O10S 652.76
Clofarabine 123318-82-1 C10H11ClFN5O3 303.68
11

Route of Synthesis

12

References

13

More Information

Vancomycin (hydrochloride)

Tags: buy 1404-93-9 IC50 | 1404-93-9 price | 1404-93-9 cost | 1404-93-9 solubility | 1404-93-9 purchase | 1404-93-9 manufacturer | 1404-93-9 research buy | 1404-93-9 order | 1404-93-9 MSDS | 1404-93-9 chemical structure | 1404-93-9 Storage condition | 1404-93-9 molecular weight | 1404-93-9 mw | 1404-93-9 datasheet | 1404-93-9 supplier | 1404-93-9 cell line | 1404-93-9 NMR | 1404-93-9 MS | 1404-93-9 IR | 1404-93-9 solubility | 1404-93-9 Safe information | 1404-93-9 Qc and Spectral Information | 1404-93-9 Clinical Information | 1404-93-9 Clinical Trial | 1404-93-9 Route of Synthesis | 1404-93-9 storage condition | 1404-93-9 diseases and conditions | 1404-93-9 flash point | 1404-93-9 boiling point | 1404-93-9 melting point | 1404-93-9 storage condition | 1404-93-9 brand